{"denoms":[{"counts":[{"groupId":"BG000","value":"51"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"101"}],"units":"Participants"}],"groups":[{"description":"Standard of Care Stem cell collection without in-vivo purging with Bortezomib. Standard of Care drugs Granulocyte colony-stimulating factor (G-CSF) +/- Mozobil (the latter if needed).\n\nNOTE: Multiparametric Flow Cytometry to be performed on samples for BOTH groups A and B\n\nGranulocyte colony-stimulating factor (G-CSF): Granulocyte colony-stimulating factor (G-CSF) will be given to all participants by injection under the skin 4 days and 1 day before stem cell collection, and then continued until the stem cell collection is completed.\n\nMozobil: Mozobil will be given to all participants by injection under the skin only if needed per Investigator.","id":"BG000","title":"Stem Cell Collection Without In-vivo Purging With Bortezomib"},{"description":"Bortezomib will be given subcutaneously (SQ) at 1.3 mg/m2 on day -11 and day -8 followed by Granulocyte colony-stimulating factor (G-CSF) given SQ on day -4 thru day -1 and continued until the collection is completed. Mozobil will be given if needed.\n\nThere must be at least 72 hours between each dose of bortezomib. NOTE: Multiparametric Flow Cytometry to be performed on samples for BOTH groups A and B\n\nBortezomib: Bortezomib will be given to Group B participants by injection under the skin 11 days and 8 days before stem cell collection.\n\nGranulocyte colony-stimulating factor (G-CSF): Granulocyte colony-stimulating factor (G-CSF) will be given to all participants by injection under the skin 4 days and 1 day before stem cell collection, and then continued until the stem cell collection is completed.\n\nMozobil: Mozobil will be given to all participants by injection under the skin only if needed per Investigator.","id":"BG001","title":"Stem Cell Collection With In-vivo Purging With Bortezomib"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"66"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"35"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"42"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"59"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"5"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"95"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"}]}